Pharmaceutical Mail. If it took a few years for the generic to reach a significant market share, Joaquín Rodrigo, president of the newly born Spanish biosimilar employers' association, Biosim, is confident that history will not repeat itself "and that a firm commitment will be made, from the beginning , by all health agents, for its introduction and use', he points out to CF.